Expression of MMR in 515 cases of endometrioid adenocarcinoma and its correlation with clinicopathological features

Expression of MMR in 515 cases of endometrioid adenocarcinoma and its correlation with clinicopathological features

Background and purpose: Lynch syndrome associated endometrial carcinoma has unique clinicopathological features and treatment methods. The detection of mismatch repair (MMR) protein expression by immunohistochemical (IHC) staining in patients with newly diagnosed endometrial cancer can effectively s...

Full description

Bibliographic Details
Main Author:	WU Quan, GUO Jingwei, LEI Yuxin, HU Xiaoru, WANG Zhe
Format:	Article
Language:	English
Published:	Editorial Office of China Oncology 2022-12-01
Series:	Zhongguo aizheng zazhi
Subjects:	\|endometrioid adenocarcinoma\|deficient mismatch repair\|microsatellite instability\|immunohistochemistry\|immunotherapy
Online Access:	http://www.china-oncology.com/fileup/1007-3639/PDF/1675314929388-647068398.pdf

Similar Items

Dedifferentiated endometrioid adenocarcinoma of the uterus: A case series and review of literature
by: C. Goh, et al.
Published: (2020-05-01)

Challenges and Therapeutic Opportunities in the dMMR/MSI-H Colorectal Cancer Landscape
by: Núria Mulet-Margalef, et al.
Published: (2023-02-01)

Treatments after Immune Checkpoint Inhibitors in Patients with dMMR/MSI Metastatic Colorectal Cancer
by: Quang Loc Bui, et al.
Published: (2022-01-01)

Mismatch repair deficiency screening in colorectal carcinoma by a four-antibody immunohistochemical panel in Pakistani population and its correlation with histopathological parameters
by: Atif Ali Hashmi, et al.
Published: (2017-06-01)

Microsatellite Instability: From the Implementation of the Detection to a Prognostic and Predictive Role in Cancers
by: Martina Amato, et al.
Published: (2022-08-01)

Microsatellite instability screening in colorectal carcinoma: immunohistochemical analysis of MMR proteins in correlation with clinicopathological features and Ki-67 protein expression
by: Noha N. Yassen, et al.
Published: (2023-10-01)

Endometrioid adenocarcinoma in pregnancy: case report
by: E V Musina, et al.
Published: (2016-04-01)

Microsatellite instability and mismatch repair protein deficiency: equal predictive markers?
by: Maja L. Nádorvári, et al.
Published: (2024-04-01)

Association of clinicopathological features with DNA mismatch repair status among colorectal cancer patients presenting to a Tertiary Care Cancer Hospital
by: Gayathri G Nair, et al.
Published: (2022-01-01)

Neoadjuvant Immunotherapy for MSI-H/dMMR Locally Advanced Colorectal Cancer: New Strategies and Unveiled Opportunities
by: Xuan Zhang, et al.
Published: (2022-03-01)

Retrospective Analysis of the Correlation of MSI-h/dMMR Status and Response to Therapy for Endometrial Cancer: RAME Study, a Multicenter Experience
by: Valentina Tuninetti, et al.
Published: (2023-07-01)

Microsatellite Status Detection in Gastrointestinal Cancers: PCR/NGS Is Mandatory in Negative/Patchy MMR Immunohistochemistry
by: Federica Zito Marino, et al.
Published: (2022-04-01)

Clinicopathological characteristics of high microsatellite instability/mismatch repair-deficient colorectal cancer: A narrative review
by: Wei-Jian Mei, et al.
Published: (2022-12-01)

“Cheerios in the lung” as first metastases from endometrial endometrioid adenocarcinoma with adequate response to immunotherapy
by: Chiara De Nardo, et al.
Published: (2023-09-01)

Clinicopathologic significance of mismatch repair protein expression in endometrioid endometrial cancer
by: Mi-Kyung Kim, et al.
Published: (2023-09-01)

Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours
by: Birgit S. Geurts, et al.
Published: (2023-03-01)

Comparison of standard mismatch repair deficiency and microsatellite instability tests in a large cancer series
by: Maja L. Nádorvári, et al.
Published: (2024-02-01)

Mesonephric-like Differentiation of Endometrial Endometrioid Carcinoma: Clinicopathological and Molecular Characteristics Distinct from Those of Uterine Mesonephric-like Adenocarcinoma
by: Sujin Park, et al.
Published: (2021-08-01)

Comparison of Clinical and Histopathological Parameters amongst Microsatellite Unstable and Microsatellite Stable Cases of Colorectal Carcinomas in an Indian Setting
by: Divya Shelly, et al.
Published: (2021-09-01)

Heterogenous loss of mismatch repair (MMR) protein expression: a challenge for immunohistochemical interpretation and microsatellite instability (MSI) evaluation
by: Aoife J McCarthy, et al.
Published: (2019-04-01)

Microsatellite Instability in Young Women with Endometrioid type Endometrial Cancer
by: MR Abbaszadegan, et al.
Published: (2009-09-01)

Clinicopathological and molecular features of sporadic colorectal cancers with DNA mismatch repair deficiency: A single center experience
by: Ali Koyuncuer, et al.
Published: (2020-12-01)

Expression of PD-L1 in Microsatellite Instability High Tumours: A Retrospective Study
by: Dinisha Einstien, et al.
Published: (2023-06-01)

Long-Term Survival and Clinicopathological Implications of DNA Mismatch Repair Status in Endometrioid Endometrial Cancers in Hong Kong Chinese Women
by: Jacqueline Ho Sze Lee, et al.
Published: (2021-10-01)

Gynecological Cancers Caused by Deficient Mismatch Repair and Microsatellite Instability
by: Madhura Deshpande, et al.
Published: (2020-11-01)

Constitutional Mismatch Repair Deficiency Syndrome in a patient from India
by: Chandramallika Paul, et al.
Published: (2020-12-01)

The Role of Immunohistochemistry Markers in Endometrial Cancer with Mismatch Repair Deficiency: A Systematic Review
by: Amelia Favier, et al.
Published: (2022-08-01)

Heterogeneity of Mismatch Repair Status and Microsatellite Instability between Primary Tumour and Metastasis and Its Implications for Immunotherapy in Colorectal Cancers
by: Camille Evrard, et al.
Published: (2022-04-01)

Managing Difficulties of Microsatellite Instability Testing in Endometrial Cancer-Limitations and Advantages of Four Different PCR-Based Approaches
by: Janna Siemanowski, et al.
Published: (2021-03-01)

Clinical Testing for Mismatch Repair in Neoplasms Using Multiple Laboratory Methods
by: Richard K. Yang, et al.
Published: (2022-09-01)

Immune Checkpoint Inhibition in Metastatic Colorectal Cancer Harboring Microsatellite Instability or Mismatch Repair Deficiency
by: Romain Cohen, et al.
Published: (2021-03-01)

Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy
by: Pengfei Zhao, et al.
Published: (2019-05-01)

The Role and Significance of Wnt5a in Regulating Epithelial–Mesenchymal Transition in Endometrioid Adenocarcinoma
by: Yang N, et al.
Published: (2021-08-01)

Rapidly growing ovarian endometrioid adenocarcinoma involving the vagina: A case report
by: Sunghun Na, et al.
Published: (2011-12-01)

Mismatch repair deficiency testing in Lynch syndrome-associated urothelial tumors
by: Maria Rasmussen, et al.
Published: (2023-04-01)

Prognostic value of Lynch syndrome, BRAFV600E, and RAS mutational status in dMMR/MSI‐H metastatic colorectal cancer in a pooled analysis of Dutch and French cohorts
by: Koen Zwart, et al.
Published: (2023-08-01)

Comparison of Methods for Testing Mismatch Repair Status in Endometrial Cancer
by: Marta Mendiola, et al.
Published: (2023-09-01)

Immunotherapy with Immune Checkpoint Inhibitors for Advanced Colorectal Cancer: A Promising Individualized Treatment Strategy
by: Ying Yang, et al.
Published: (2023-04-01)

Panel of Villin, Pro-Ex-C, Estrogen Receptor and Progesterone Receptor Expressions Could Help in Differentiation Between Endocervical and Endometrioid Adenocarcinoma
by: Mariem ELFEKY, et al.
Published: (2018-01-01)

Mismatch Repair Deficiency and Microsatellite Instability
by: Sandra Schöniger, et al.
Published: (2022-08-01)